Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome

Abstract

As recent clinical and animal studies have indicated, colchicine, with its anti-fibrotic, anti-mitotic and anti-inflammatory activities, has suppressive effects in the pathogenesis of Peyronie's disease.